| Bismuth-213 for targeted radionuclide therapy: from atom to bedside S Ahenkorah, I Cassells, CM Deroose, T Cardinaels, AR Burgoyne, ... Pharmaceutics 13 (5), 599, 2021 | 85 | 2021 |
| Retention of [18F] fluoride on reversed phase HPLC columns D Ory, J Van den Brande, T de Groot, K Serdons, M Bex, L Declercq, ... Journal of Pharmaceutical and Biomedical Analysis 111, 209-214, 2015 | 61 | 2015 |
| Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer Y Dekempeneer, V Caveliers, M Ooms, D Maertens, M Gysemans, ... Molecular Pharmaceutics 17 (9), 3553-3566, 2020 | 53 | 2020 |
| Preclinical evaluation of [18F] JNJ42259152 as a PET tracer for PDE10A S Celen, M Koole, M Ooms, M De Angelis, I Sannen, J Cornelis, J Alcazar, ... Neuroimage 82, 13-22, 2013 | 41 | 2013 |
| Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice M Ooms, R Rietjens, JR Rangarajan, K Vunckx, S Valdeolivas, F Maes, ... Neurobiology of aging 35 (12), 2858-2869, 2014 | 38 | 2014 |
| Synthesis and preclinical evaluation of [11C] MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL) M Ahamed, B Attili, D van Veghel, M Ooms, P Berben, S Celen, M Koole, ... European journal of medicinal chemistry 136, 104-113, 2017 | 27 | 2017 |
| 3p-C-NETA: A versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals S Ahenkorah, E Murce, C Cawthorne, JP Ketchemen, CM Deroose, ... Theranostics 12 (13), 5971, 2022 | 23 | 2022 |
| Radiolabeling of Human Serum Albumin With Terbium-161 Using Mild Conditions and Evaluation of in vivo Stability I Cassells, S Ahenkorah, AR Burgoyne, M Van de Voorde, CM Deroose, ... Frontiers in Medicine 8, 675122, 2021 | 21 | 2021 |
| Production of Sm-153 with very high specific activity for targeted radionuclide therapy M Van de Voorde, C Duchemin, R Heinke, L Lambert, E Chevallay, ... Frontiers in Medicine 8, 675221, 2021 | 19 | 2021 |
| Inorganic radiolabeled nanomaterials in cancer therapy: a review TA Lemaître, AR Burgoyne, M Ooms, TN Parac-Vogt, T Cardinaels ACS Applied Nano Materials 5 (7), 8680-8709, 2022 | 18 | 2022 |
| [18F] JNJ 42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP M Ooms, B Attili, S Celen, M Koole, A Verbruggen, K Van Laere, ... Journal of Neurochemistry 139 (5), 897-906, 2016 | 18 | 2016 |
| Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission M Ooms, S Celen, R De Hoogt, I Lenaerts, J Liebregts, G Vanhoof, ... EJNMMI radiopharmacy and chemistry 1, 1-17, 2017 | 17 | 2017 |
| Transition-metal-free synthesis of pyridine derivatives by thermal cyclization of N-propargyl enamines Y Chikayuki, T Miyashige, S Yonekawa, A Kirita, N Matsuo, H Teramoto, ... Synthesis 52 (07), 1113-1121, 2020 | 16 | 2020 |
| Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A M Ooms, S Celen, M Koole, X Langlois, M Schmidt, M De Angelis, ... Nuclear Medicine and Biology 41 (8), 695-704, 2014 | 16 | 2014 |
| Preclinical Evaluation of [155/161Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours L Wharton, SW McNeil, H Merkens, Z Yuan, M Van de Voorde, G Engudar, ... Molecules 28 (7), 3155, 2023 | 15 | 2023 |
| Bifunctional chelators for radiorhenium: Past, present and future outlook DR Melis, AR Burgoyne, M Ooms, G Gasser RSC Medicinal Chemistry 13 (3), 217-245, 2022 | 15 | 2022 |
| Discovery, radiolabeling, and evaluation of subtype-selective inhibitors for positron emission tomography imaging of brain phosphodiesterase-4D Y Wakabayashi, S Telu, RM Dick, M Fujita, M Ooms, CL Morse, JS Liow, ... ACS chemical neuroscience 11 (9), 1311-1323, 2020 | 15 | 2020 |
| A simple and automated method for 161Tb purification and ICP-MS analysis of 161Tb SW McNeil, M Van de Voorde, C Zhang, M Ooms, F Bénard, ... EJNMMI Radiopharmacy and Chemistry 7 (1), 31, 2022 | 12 | 2022 |
| Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside C Van Laere, M Koole, CM Deroose, M Van de Voorde, K Baete, ... Theranostics 14 (4), 1720, 2024 | 9 | 2024 |
| Direct comparison of [18F] AlF-NOTA-JR11 and [18F] AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist S Ahenkorah, C Cawthorne, E Murce, CM Deroose, T Cardinaels, ... Nuclear Medicine and Biology 118, 108338, 2023 | 8 | 2023 |
